Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care centre

Background & objectives: Group C and group G streptococci (together GCGS) are often regarded as commensal bacteria and their role in streptococcal disease burden is under-recognized. While reports of recovery of GCGS from normally sterile body sites are increasing, their resistance to macrolides, fluoroquinolone further warrants all invasive β haemolytic streptococci to be identified to the species level and accurately tested for antimicrobial susceptibility. This study was aimed to determine the prevalence, clinical profile, antimicrobial susceptibility and streptococcal pyrogenic exotoxin gene profile (speA, speB, speC, speF, smeZ, speI, speM, speG, speH and ssa) of GCGS obtained over a period of two years at a tertiary care centre from north India. Methods: The clinical samples were processed as per standard microbiological techniques. β-haemolytic streptococci (BHS) were characterized and grouped. Antimicrobial susceptibility of GCGS was performed using disk diffusion method. All GCGS were characterized for the presence of streptococcal pyrogenic exotoxins (spe) and spe genes were amplified by PCR method. Results: GCGS (23 GGS, 2GCS) comprised 16 per cent of β haemolytic streptococci (25/142 βHS, 16%) isolated over the study period. Of the 25 GCGS, 22 (88%) were recovered from pus, two (8%) from respiratory tract, whereas one isolate was recovered from blood of a fatal case of septicaemia. Of the total 23 GGS isolates, 18 (78%) were identified as Streptococcus dysgalactiae subsp equisimilis (SDSE, large-colony phenotype), five (21%) were Streptococcus anginosus group (SAG, small-colony phenotype). The two GCS were identified as SDSE. All GCGS isolates were susceptible to penicillin, vancomycin, and linezolid. Tetracycline resistance was noted in 50 per cent of SDSE isolates. The rates of macrolide and fluoroquinolone resistance in SDSE were low. Twelve of the 20 SDSE isolates were positive for one or more spe genes, with five of the SDSE isolates simultaneously carrying speA+ speB+ smeZ+ speF or speB+ smeZ+speF, speI+speM+speG+speH or, speI+spe M+speH or speA+ speB+ speC+ smeZ+ speF. One notable finding was the presence of spe B in four of the five isolates of the Streptococcus anginosus group. No isolate was positive for ssa. Interpretation & conclusions: Our study showed no association between GCGS isolates harbouring streptococcal pyrogenic exotoxins and disease severity. This might be attributed to the small sample size of spe-positive isolates.

[1]  T. Menon,et al.  Genotypic characterization of toxigenic group C and G streptococci isolated in Chennai, South India , 2011, Folia Microbiologica.

[2]  Haruo Watanabe,et al.  Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[3]  S. Skrede,et al.  emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  G. S. Chhatwal,et al.  Contribution of Streptococcus anginosus to Infections Caused by Groups C and G Streptococci, Southern India , 2010, Emerging infectious diseases.

[5]  P. V. Bramhachari,et al.  Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. , 2010, Journal of medical microbiology.

[6]  B. Spellerberg,et al.  E M E R G I N G I N F E C T I O N S I N V I T E D a R T I C L E Human Infections Due to Streptococcus Dysgalactiae Subspecies Equisimilis , 2022 .

[7]  M. Arvand,et al.  Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. , 2009, Journal of medical microbiology.

[8]  D. Livermore,et al.  Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. , 2008, The Journal of antimicrobial chemotherapy.

[9]  J. Carapetis,et al.  Superantigen genes in group A streptococcal isolates and their relationship with emm types. , 2008, Journal of medical microbiology.

[10]  M. McDonald,et al.  Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in Tropical Communities, Northern Australia , 2007, Emerging infectious diseases.

[11]  A. Sandgren,et al.  Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Yu-ling Zheng,et al.  Epidemiological analysis of group A streptococci recovered from patients in China. , 2006, Journal of medical microbiology.

[13]  P. Coll,et al.  Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. , 2006, Journal of medical microbiology.

[14]  Ronald N. Jones,et al.  Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). , 2006, Diagnostic microbiology and infectious disease.

[15]  M. Davies,et al.  Distribution of group A streptococcal virulence genes in group C and G streptococci , 2006 .

[16]  Ronald N. Jones,et al.  Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). , 2006, Diagnostic microbiology and infectious disease.

[17]  B. Herrmann,et al.  Identification of 43 Streptococcus Species by Pyrosequencing Analysis of the rnpB Gene , 2005, Journal of Clinical Microbiology.

[18]  P. Mathur,et al.  Prevalence of group G & group C streptococci at an Indian tertiary care centre. , 2004, The Indian journal of medical research.

[19]  T. Hasegawa,et al.  Characterization of Group C and G Streptococcal Strains That Cause Streptococcal Toxic Shock Syndrome , 2004, Journal of Clinical Microbiology.

[20]  E. Charpentier,et al.  Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. , 2003, The Journal of infectious diseases.

[21]  J. Schellekens,et al.  Site-Specific Manifestations of Invasive Group A Streptococcal Disease: Type Distribution and Corresponding Patterns of Virulence Determinants , 2003, Journal of Clinical Microbiology.

[22]  Gail Williams Group C and G Streptococci Infections: Emerging Challenges , 2003, American Society for Clinical Laboratory Science.

[23]  D. Bessen,et al.  Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. , 2003, FEMS microbiology letters.

[24]  E. Straube,et al.  Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). , 2002, FEMS immunology and medical microbiology.

[25]  K. Yuen,et al.  Group G Beta-Hemolytic Streptococcal Bacteremia Characterized by 16S Ribosomal RNA Gene Sequencing , 2001, Journal of Clinical Microbiology.

[26]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[27]  P. Vandamme,et al.  Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. , 1996, International journal of systematic bacteriology.

[28]  M. Kotb,et al.  Bacterial pyrogenic exotoxins as superantigens , 1995, Clinical microbiology reviews.

[29]  D. Beighton,et al.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections , 1992, Journal of clinical microbiology.

[30]  K. Ruoff Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen , 1988, Clinical Microbiology Reviews.